BCR and neoplasm: PI3Kδ is an important messenger in B-cell receptor (BCR) signaling, and PI3Kδ signaling pathways are commonly overactive in B-cell tumors [14, 15]and increase proliferation, development and survival of tumor cells [16, 17].